USE CASE

Bold Security for
Healthcare, Pharma, and Life Sciences

See Bold live

Healthcare, pharma, and life sciences organizations handle data that carries both regulatory consequence and competitive value: patient health information, drug formulation data, clinical trial protocols, genomic research, and compound libraries representing years of R&D investment.

The risk lives in the daily actions of clinicians, researchers, and operations staff authorized users who have legitimate access to sensitive systems and the ability to move data outside of them. Traditional tools generate alerts - they do not control behavior.

Bold controls the endpoint directly giving security teams real-time visibility into how sensitive data is being handled and the ability to intervene before an incident becomes a reportable event.

Stop PHI and Clinical IP From Leaving Before It Becomes a Breach

The most common source of data loss in healthcare and pharma is not a sophisticated attack, it is an authorized user, a clinician copying patient records, a researcher downloading trial data, an employee departing with proprietary documentation.

Bold monitors user behavior at the endpoint in real time detecting bulk exports, unusual file movement, and data being moved to personal accounts or external systems. When a risky action occurs, Bold intervenes before the transfer completes.

Enforce PHI Controls Without Cloud Exposure

Sending file content to the cloud for analysis creates its own HIPPA exposure.

Bold runs entirely on the endpoint. No file content leaves the device for processing. PHI is identified and controlled locally, in real time, with no latency and no third-party cloud risk. The tool used to detect a problem never becomes one.

Track the Full Lifecycle of Sensitive Files

Bold captures the complete chain of custody for every sensitive file export, copy, rename, zip, upload across clinical systems, research platforms, and collaboration tools.

When an incident occurs, the full sequence of events is already documented.

Reduce Ecosystem Oversharing Without Slowing Operations

Healthcare and pharma organizations regularly share sensitive data with vendors, research partners, CROs, and outside counsel.

Bold prevents sensitive data from moving to unmanaged systems or unintended external parties while redirecting users to approved workflows in real time. Email misdelivery is a material risk and Bold intervenes before a sensitive file reaches the wrong recipient.

Govern AI Adoption Without Regulatory Exposure

Clinicians, researchers, and administrative staff are adopting AI tools across every function - blanket restrictions are not a viable long-term strategy.

Bold detects when PHI or proprietary research data is entered into external AI tools including content captured in screenshots and images and coaches users in real time without blocking their workflow.

Business Impact

With Bold, Insurance Organizations:

Stop PHI and clinical IP loss before it becomes reportable

Enforce endpoint controls without cloud exposure

Track full file lineage across clinical and research environments

Detect insider risk before departure

Govern AI adoption in regulated contexts Replace policy noise with real-time intervention

Bold secures regulated patient data and proprietary research IP directly at the endpoint without slowing the business.

What Bold delivers

Prevents proprietary models, underwriting playbooks, and aggregated books of business from leaving through copy, upload, AI tools, personal accounts, or bulk extraction.

Stops high-impact data movement before it becomes a reportable event, reducing regulatory exposure, breach notification risk, and reputational damage.

Prevents sensitive data from moving to personal accounts, unmanaged systems, or unintended external parties, while redirecting users to approved workflows in real time.

Identifies abnormal aggregation, bulk exports, and unusual access patterns before departure by combining user behavior and data sensitivity in one investigative view.

Prevents regulated policyholder data and proprietary models from entering public AI tools while allowing lower-risk operational use to proceed.

Key Protection Outcomes for Insurance Organizations

Even in tightly locked-down financial environments, risk still materializes at the point of user action:

Your differentiated risk intelligence stays protected at the point of user action.

Collaboration continues. Leakage does not.

Security moves from reactive investigation to early intervention.

Innovation advances without compromising defensibility.

Deal teams, executives, and relationship managers with legitimate elevated access and external counterparties

Misaddressed emails sent under time pressure

The outcome

Bold brings insurance-aware, on-device AI classification to the endpoint - where real risk occurs.